Skip to main content

Day: May 3, 2021

ContraFect Announces Issuance of Composition of Matter Patent for CF-370 by the United States Patent and Trademark Office

YONKERS, N.Y., May 03, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced that the United States Patent and Trademark Office issued U.S. Patent No. 10,988,520 (the ‘520 patent), on April 27, 2021 for CF-370, the company’s second potential therapeutic product candidate. The ‘520 patent, which is owned by ContraFect, expires in March of 2039, and is the latest U.S. patent to issue from the company’s DLA patent portfolio. The ‘520 patent, entitled “Lysin-Antimicrobial Peptide (AMP) Polypeptide Constructs, Lysins, Isolated Polynucleotides Encoding Same and...

Continue reading

Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2  

COVAXIN effectively neutralizes Brazil variant along with UK variant and India double mutant variantPotential effectiveness against multiple variants reduces the possibility of mutant virus escapeAccording to World Health Organization, the double mutant variant of SARS-CoV-2 has spread to at least 17 countriesMALVERN, Pa., May 03, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that in a new study, scientists at Indian Council of Medical Research (ICMR)-National Institute of Virology have found that COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2. As previously disclosed, a study...

Continue reading

FTI Consulting Completes Acquisition of The Rhodes Group

WASHINGTON, May 03, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it has completed its acquisition of The Rhodes Group, a leading construction consulting firm with offices in Pittsburgh and Houston. With the completion of the acquisition, approximately 40 billable professionals from The Rhodes Group, including one Senior Managing Director and three Managing Directors, join the Construction & Environmental Solutions practice within the Forensic and Litigation Consulting segment at FTI Consulting. Andrew Rhodes, the Founder and President of The Rhodes Group, joins FTI Consulting as a Senior Managing Director. Founded in 1999, The Rhodes Group provides construction advisory, forensic accounting and expert testimony services to clients throughout the entire project lifecycle, from preconstruction...

Continue reading

Diversified Royalty Corp. Announces Increase to the Mr. Lube Royalty Rate, Additions to the Mr. Lube Royalty Pool, Amendment of ML Royalties LP Credit Facility and May 2021 Cash Dividend

VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB) (the “Corporation” or “DIV”) and Mr. Lube Canada Limited Partnership (“Mr. Lube”) announced today that effective May 1, 2021, the royalty rate paid by Mr. Lube to the Corporation on non-tire sales at flagship locations (the “Mr. Lube Royalty Rate”) has been increased by 0.5% from 7.45% to 7.95%. In addition, the Mr. Lube royalty pool (the “Mr. Lube Royalty Pool”) has been adjusted to include the royalties from 13 new Mr. Lube locations. With the adjustment for these 13 openings, the Mr. Lube Royalty Pool now includes 135 flagship locations. As previously announced, on November 9, 2020, DIV and Mr. Lube entered into an amendment (the “LP Amendment”) to the amended and restated limited partnership agreement of DIV’s direct...

Continue reading

Green Plains Partners Reports First Quarter 2021 Financial Results

Results for the First Quarter of 2021Net income of $10.7 million, or $0.45 per common unit Adjusted EBITDA of $13.8 million and distributable cash flow of $11.7 million Quarterly cash distribution of $0.12 per unit Distribution coverage ratio of 4.13x, LTM distribution coverage ratio of 4.02xOMAHA, Neb., May 03, 2021 (GLOBE NEWSWIRE) — Green Plains Partners LP (NASDAQ:GPP) today announced financial and operating results for the first quarter of 2021. Net income attributable to the partnership was $10.7 million, or $0.45 per common unit, for the first quarter of 2021 compared with net income of $10.4 million, or $0.44 per common unit, for the same period in 2020. The partnership also reported adjusted EBITDA of $13.8 million and distributable cash flow of $11.7 million for the first quarter of 2021, compared with adjusted EBITDA...

Continue reading

GasLog Ltd. To Hold Special General Meeting of Shareholders

Piraeus, Greece, May 03, 2021 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog”) (NYSE: GLOG) today announced that it has called a special general meeting of shareholders (the “Special Meeting”), to be held on June 4, 2021, to consider and vote on the proposal to approve (i) the previously announced merger contemplated by that certain agreement and plan of merger, dated as of February 21, 2021 (as amended, the “Merger Agreement”), by and among GasLog, GEPIF III Crown Bidco L.P., a Cayman Islands exempted company, and GEPIF III Crown MergerCo Limited, a Bermuda exempted company (“Merger Sub”), pursuant to which Merger Sub will merge with and into GasLog with GasLog as the surviving company in the merger, (ii) the Merger Agreement and (iii) the statutory merger agreement contemplated by the Merger Agreement. Holders of record of GasLog’s...

Continue reading

Ebix Announces Appointment of Priyanka Kaul to Its Board of Directors

JOHNS CREEK, Ga., May 03, 2021 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, e-governance and healthcare industries, today announced the appointment of Ms. Priyanka Kaul as a new independent director to the Ebix Board. In a career spanning 22 years, Priyanka has held various leadership positions including being the CEO of Forbes India and Division President of Network 18 Group (CNBC TV 19 and CNN TV18). She has also been the Chief Marketing and Revenue Officer at one of India’s leading media groups – NDTV. An environmentalist to the core, she has pioneered and conceptualized India’s best known and award-winning environment campaigns for brands like: Toyota (Greenathon), Aircel (Save Our Tigers), Coca-Cola (Support my...

Continue reading

Xebec Expands U.S Manufacturing Capacity with Acquisition of Tennessee Based Nortec

Tennessee based Nortec will give Xebec additional manufacturing and product development capabilities in the United States MONTREAL, May 03, 2021 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSX: XBC) (“Xebec”), a global provider of clean energy solutions, is pleased to announce on April 30, 2021, it has closed the acquisition of all the outstanding shares of Tennessee based Nortekbelair Corporation (“Nortec”). Nortec’s principal, Mike Zarif, Ph.D, will remain with Nortec after the acquisition and continue his focus on R&D and product development within the company. With this acquisition, Xebec’s manufacturing footprint will expand with an 18,500 sq. foot facility in Maryville, Tennessee, and will provide the company with key personnel to establish a “Center of Excellence” for its dehydration products comprised of compressed air...

Continue reading

Gilat Enters Strategic Agreement Valued at Tens of Millions of Dollars with a Large Government Corporation in Asia Pacific

The equipment and multi-year managed-services contract includes enterprise connectivity, with a large potential for expansion to additional applicationsMulti-Year Strategic Agreement Entered in Asia Pacific for Broadband Connectivity Equipment and Managed ServicesAgreement valued at tens of millions of dollars with potential of significant expansionPETAH TIKVA, Israel, May 03, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that Gilat entered a strategic agreement valued at tens of millions of dollars, including a potential for significant project expansions, with a large government corporation in Asia Pacific. The equipment and multi-year managed-services contract will enable connectivity...

Continue reading

Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE™ for Treatment of Macular Edema Associated with Uveitis

ALPHARETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) for the treatment of macular edema associated with uveitis. Clearside’s resubmission is a full and complete response to all of the items identified in the Complete Response Letter (CRL) received from the FDA on October 18, 2019. Clearside believes this application will be considered a Class 2 resubmission, with a targeted six-month review timeline under the Prescription Drug User Fee Act. “The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.